Bright Minds Biosciences Inc. (CSE: DRUG)

Bright Minds Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 17, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	361	7	8	28	107	-
Market Cap Growth	-19.09%	-19.09%	-71.17%	-73.71%	-	-
Enterprise Value	356	0	0	19	85	-
Last Close Price	51.69	1.47	2.15	8.50	45.20	-
PB Ratio	42.24	1.19	1.23	2.67	5.51	-
P/TBV Ratio	1.19	1.19	1.23	2.67	5.51	-
Debt / Equity Ratio	0.02	0.02	0.01	0.01	-	-
Quick Ratio	10.91	10.91	24.16	8.00	31.12	5.30
Current Ratio	11.32	11.32	24.26	8.11	31.38	5.82
Return on Equity (ROE)	-46.18%	-46.18%	-86.02%	-99.95%	-85.94%	-124.04%
Return on Assets (ROA)	-25.19%	-25.19%	-47.45%	-57.32%	-51.52%	-61.70%
Return on Capital (ROIC)	-26.53%	-26.53%	-51.86%	-61.21%	-53.54%	-76.64%
Earnings Yield	-1.26%	-42.70%	-90.90%	-53.20%	-8.09%	-
FCF Yield	-28.20%	-28.20%	-86.61%	-48.30%	-6.84%	-
Buyback Yield / Dilution	-15.87%	-15.87%	-50.57%	-37.64%	-148.42%	-74.24%
Total Shareholder Return	-15.87%	-15.87%	-50.57%	-37.64%	-148.42%	-74.24%

Source: S&P Capital IQ. Standard template. Financial Sources.